We evaluated mRNA expression of IGFBP4, IGF1 and IGF1R in thyroid cancers, adenomas and hyperplastic nodules in comparison with their benign counterparts without observing any statistically significant differences (Table 3). This evidence concerns the gene IGF1R and thyroid cancer.